Literature DB >> 30611552

Association between estrogen receptor 1 (ESR1) and leukemia inhibitory factor (LIF) polymorphisms can help in the prediction of recurrent implantation failure.

Laura Diniz Vagnini1, Adriana Renzi2, Bruna Petersen2, Maria do Carmo Tomitão Canas2, Claudia Guilhermino Petersen3, Ana Lucia Mauri3, Mariana Coltri Mattila4, Juliana Ricci4, Felipe Dieamant3, João Batista Alcantara Oliveira3, Ricardo Luiz Razera Baruffi3, José Gonçalves Franco3.   

Abstract

OBJECTIVE: To investigate an association between polymorphisms related to the implantation process that together could help in the prediction of recurrent implantation failure (RIF).
DESIGN: Cohort study.
SETTING: Private fertility center and reproductive genetics laboratory. PATIENT(S): Forty-four women presenting RIF, who were included in study group (RIF group), and two control groups, one with 63 women who were attended at our service and became pregnant after the first IVF/intracytoplasmic sperm injection attempt (control group I) and other with 65 fertile women who had at least two children without any treatment and no history of miscarriage (control group II). INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Genotyping was performed in the intron region of TP63, VEGFA, MMP2, ESR1, and ESR2 genes and in the 3' untranslated region of the LIF gene on genomic DNA using real-time polymerase chain reaction. RESULT(S): The presence of ESR1/AA (rs12199722) and LIF/GT (rs929271) genotypes was more frequent in the RIF group, leading to a 7.9-fold increase in the chance of women presenting with RIF when compared with women who became pregnant on their first cycle of IVF/intracytoplasmic sperm injection and a 2.8-fold increase when compared with women who became pregnant without treatment. CONCLUSION(S): The association between ESR1 and LIF polymorphisms can help in the prediction of RIF.
Copyright © 2018 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ESR1; IVF/ICSI; LIF; recurrent implantation failure (RIF)

Mesh:

Substances:

Year:  2019        PMID: 30611552     DOI: 10.1016/j.fertnstert.2018.11.016

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

Review 1.  Polymorphisms of vascular endothelial growth factor and recurrent implantation failure: a systematic review and meta-analysis.

Authors:  Hong Zeng; Lian Hu; Hebin Xie; Wenmin Ma; Song Quan
Journal:  Arch Gynecol Obstet       Date:  2021-04-23       Impact factor: 2.344

Review 2.  Mouse Cre drivers: tools for studying disorders of the human female neuroendocrine-reproductive axis†.

Authors:  Anat Chemerinski; Chang Liu; Sara S Morelli; Andy V Babwah; Nataki C Douglas
Journal:  Biol Reprod       Date:  2022-05-17       Impact factor: 4.161

Review 3.  The emerging role of leukemia inhibitory factor in cancer and therapy.

Authors:  Cen Zhang; Juan Liu; Jianming Wang; Wenwei Hu; Zhaohui Feng
Journal:  Pharmacol Ther       Date:  2020-11-28       Impact factor: 12.310

4.  Integrated Analysis of Multiple Microarrays Based on Raw Data Identified Novel Gene Signatures in Recurrent Implantation Failure.

Authors:  Hong Zeng; Yu Fu; Lang Shen; Song Quan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-07       Impact factor: 5.555

5.  Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.

Authors:  Xiaowei Zhou; Bufang Xu; Dan Zhang; Xiaoping Jiang; Hsun-Ming Chang; Peter C K Leung; Xiaoyu Xia; Aijun Zhang
Journal:  Front Cell Dev Biol       Date:  2020-02-25

Review 6.  Genetic Regulation of Physiological Reproductive Lifespan and Female Fertility.

Authors:  Isabelle M McGrath; Sally Mortlock; Grant W Montgomery
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.